Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4342)
All Articles published online
|
Jan 14, 2006 (publication date) through Nov 24, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Sastre J, García-Saenz JA, Díaz-Rubio E. Chemotherapy for gastric cancer. World J Gastroenterol 2006; 12(2): 204-213 [PMID: 16482619 DOI: 10.3748/wjg.v12.i2.204] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v12/i2/204.htm |
| Number | Citing Articles |
| 1 |
Dimitra Florou, Christos Patsis, Alexandros Ardavanis, Andreas Scorilas. Effect of doxorubicin, oxaliplatin, and methotrexate administration on the transcriptional activity ofBCL-2family gene members in stomach cancer cells. Cancer Biology & Therapy 2013; 14(7): 587 doi: 10.4161/cbt.24591
|
| 2 |
Cristina Grávalos, Carlos Gómez-Martín, Fernando Rivera, Inmaculada Alés, Bernardo Queralt, Antonia Márquez, Ulpiano Jiménez, Vicente Alonso, Rocío García-Carbonero, Javier Sastre, Ramon Colomer, Hernán Cortés-Funes, Antonio Jimeno. Phase II study of trastuzumab and cisplatin as first-line therapy in patients with HER2-positive advanced gastric or gastroesophageal junction cancer. Clinical and Translational Oncology 2011; 13(3): 179 doi: 10.1007/s12094-011-0637-6
|
| 3 |
Jia Wei, Baorui Liu, Lifeng Wang, Xiaoping Qian, Yitao Ding, Lixia Yu. Synergistic interaction between tetrandrine and chemotherapeutic agents and influence of tetrandrine on chemotherapeutic agent-associated genes in human gastric cancer cell lines. Cancer Chemotherapy and Pharmacology 2007; 60(5): 703 doi: 10.1007/s00280-007-0416-9
|
| 4 |
Sehem Ghazala, Jawad Bilal, Irbaz Bin Riaz. Advanced gastric cancer linitis plastica presented with disseminated intravascular coagulation. BMJ Case Reports 2016; : bcr2016217675 doi: 10.1136/bcr-2016-217675
|
| 5 |
Xiang Wang, Song Tang, Xiang Cui, Jinwei Yang, Chunyu Geng, Cong Chen, Ning Zhou, Yumin Li. Cytokine-induced killer cell/dendritic cell–cytokine-induced killer cell immunotherapy for the postoperative treatment of gastric cancer. Medicine 2018; 97(36): e12230 doi: 10.1097/MD.0000000000012230
|
| 6 |
F De Vita, F Giuliani, M Orditura, E Maiello, G Galizia, N Di Martino, F Montemurro, G Cartenì, L Manzione, S Romito, V Gebbia, F Ciardiello, G Catalano, G Colucci. Adjuvant chemotherapy with epirubicin, leucovorin, 5-fluorouracil and etoposide regimen in resected gastric cancer patients: a randomized phase III trial by the Gruppo Oncologico Italia Meridionale (GOIM 9602 Study). Annals of Oncology 2007; 18(8): 1354 doi: 10.1093/annonc/mdm128
|
| 7 |
Elisabete Fernandes, Rui Freitas, Dylan Ferreira, Janine Soares, Rita Azevedo, Cristiana Gaiteiro, Andreia Peixoto, Sara Oliveira, Sofia Cotton, Marta Relvas-Santos, Luis Pedro Afonso, Carlos Palmeira, Maria José Oliveira, Rita Ferreira, André M. N. Silva, Lúcio Lara Santos, José Alexandre Ferreira. Nucleolin-Sle A Glycoforms as E-Selectin Ligands and Potentially Targetable Biomarkers at the Cell Surface of Gastric Cancer Cells. Cancers 2020; 12(4): 861 doi: 10.3390/cancers12040861
|
| 8 |
Koji Oba, Satoshi Teramukai, Michiya Kobayashi, Takanori Matsui, Yasuhiro Kodera, Junichi Sakamoto. Efficacy of adjuvant immunochemotherapy with polysaccharide K for patients with curative resections of gastric cancer. Cancer Immunology, Immunotherapy 2007; 56(6): 905 doi: 10.1007/s00262-006-0248-1
|
| 9 |
Fernando Rivera, Alfredo Carrato, Cristina Grávalos, Carles Pericay, Javier Sastre, Enrique Aranda. Recommendations on current approach to gastric cancer. Clinical and Translational Oncology 2009; 11(8): 518 doi: 10.1007/s12094-009-0396-9
|
| 10 |
Felipe Pantoja Mesquita, Laine Celestino Pinto, Bruno Moreira Soares, Adrhyann Jullyanne de Sousa Portilho, Emerson Lucena da Silva, Ingryd Nayara de Farias Ramos, André Salim Khayat, Caroline Aquino Moreira-Nunes, Mirna Marques Bezerra, Eliza de Lucas Chazin, Thatyana Rocha Alves Vasconcelos, Rommel Mario Rodríguez Burbano, Maria Elisabete Amaral de Moraes, Raquel Carvalho Montenegro. Small benzothiazole molecule induces apoptosis and prevents metastasis through DNA interaction and c-MYC gene supression in diffuse-type gastric adenocarcinoma cell line. Chemico-Biological Interactions 2018; 294: 118 doi: 10.1016/j.cbi.2018.08.006
|
| 11 |
Yung-Jue Bang. Advances in the Management of HER2-positive Advanced Gastric and Gastroesophageal Junction Cancer. Journal of Clinical Gastroenterology 2012; 46(8): 637 doi: 10.1097/MCG.0b013e3182557307
|
| 12 |
Daniel V. Catenacci, Joseph Chao, Kei Muro, Salah Eddin Al-Batran, Samuel J. Klempner, Zev A. Wainberg, Manish A. Shah, Sun Young Rha, Atsushi Ohtsu, Astra M. Liepa, Holly Knoderer, Anindya Chatterjee, Eric Van Cutsem. Toward a Treatment Sequencing Strategy: A Systematic Review of Treatment Regimens in Advanced Gastric Cancer/Gastroesophageal Junction Adenocarcinoma. The Oncologist 2021; 26(10): e1704 doi: 10.1002/onco.13907
|
| 13 |
Pegah Mousavi, Ali Ahmadi, Shakila Behzadifar, Javad Mohammadnejad, Seyed Mohammad Hosseini. Gastric Cancer - Progress and Challenges in the Era of Precision Medicine. 2024; doi: 10.5772/intechopen.1005783
|
| 14 |
Fenghua Wang, Zhiqiang Wang, Ningning Zhou, Xin An, Ruihua Xu, Youjian He, Yuhong Li. Phase II Study of Biweekly Paclitaxel Plus Infusional 5-Fluorouracil and Leucovorin as First-Line Chemotherapy in Patients With Advanced Gastric Cancer. American Journal of Clinical Oncology 2011; 34(4): 401 doi: 10.1097/COC.0b013e3181e84b63
|
| 15 |
Hyun-Dong Chae. Should surgical oncologists know about and perform systemic therapy for gastric cancer?. Foregut Surgery 2024; 4(1): 1 doi: 10.51666/fs.2024.4.e2
|
| 16 |
Tae Kyung Ha, Ji Yeong An, Ho Geun Youn, Jae Hyung Noh, Tae Sung Sohn, Sung Kim. Surgical Outcome of Synchronous Second Primary Cancer in Patients with Gastric Cancer. Yonsei Medical Journal 2007; 48(6): 981 doi: 10.3349/ymj.2007.48.6.981
|
| 17 |
Sheng-Zhang Lin, Hong-Fei Tong, Tao You, Yao-Jun Yu, Wei-Jun Wu, Cong Chen, Wei Zhang, Bing Ye, Chun-Ming Li, Zhi-Qiang Zhen, Jia-Rong Xu, Jun-Liang Zhou. Palliative gastrectomy and chemotherapy for stage IV gastric cancer. Journal of Cancer Research and Clinical Oncology 2007; 134(2): 187 doi: 10.1007/s00432-007-0268-z
|
| 18 |
Yiding Wang, Xuejun Gan, Xiaojing Cheng, Yongning Jia, Gangjian Wang, Xiaohuan Tang, Hong Du, Xiaomei Li, Xijuan Liu, Xiaofang Xing, Jiafu Ji, Ziyu Li. ABCC2 induces metabolic vulnerability and cellular ferroptosis via enhanced glutathione efflux in gastric cancer. Clinical and Translational Medicine 2024; 14(8) doi: 10.1002/ctm2.1754
|
| 19 |
Mallika Tewari, Akhileshwar Kumar, RR Mishra, Mohan Kumar, Hari S Shukla. HER2 Expression in Gastric and Gastroesophageal Cancer: Report from a Tertiary Care Hospital in North India. Indian Journal of Surgery 2015; 77(S2): 447 doi: 10.1007/s12262-013-0871-y
|
| 20 |
B. Xiong, L. Ma, Y. Cheng, C. Zhang. RETRACTED: Clinical effectiveness of neoadjuvant chemotherapy in advanced gastric cancer: An updated meta-analysis of randomized controlled trials. European Journal of Surgical Oncology (EJSO) 2014; 40(10): 1321 doi: 10.1016/j.ejso.2014.01.006
|
| 21 |
Manish A. Shah, Zev A. Wainberg, Daniel V. T. Catenacci, Howard S. Hochster, James Ford, Pamela Kunz, Fa-Chyi Lee, Howard Kallender, Fabiola Cecchi, Daniel C. Rabe, Harold Keer, Anne-Marie Martin, Yuan Liu, Robert Gagnon, Peter Bonate, Li Liu, Tona Gilmer, Donald P. Bottaro, Jose Luis Perez-Gracia. Phase II Study Evaluating 2 Dosing Schedules of Oral Foretinib (GSK1363089), cMET/VEGFR2 Inhibitor, in Patients with Metastatic Gastric Cancer. PLoS ONE 2013; 8(3): e54014 doi: 10.1371/journal.pone.0054014
|
| 22 |
L. de Mestier, J. Volet, O. Bouché. Médecine personnalisée en cancérologie digestive. 2013; : 243 doi: 10.1007/978-2-8178-0527-6_17
|
| 23 |
Sa-Hong Kim, Hyuk-Joon Lee, Ji-Hyeon Park, Jong-Ho Choi, Shin-Hoo Park, Hwi-Nyeong Choe, Seung-Young Oh, Yun-Suhk Suh, Seong-Ho Kong, Do-Joong Park, Han-Kwang Yang. Proposal of a New TNM Classification for Gastric Cancer: Focusing on pN3b and Cytology-Positive (CY1) Disease. Journal of Gastric Cancer 2019; 19(3): 329 doi: 10.5230/jgc.2019.19.e33
|
| 24 |
Li Bai, Kunbo Dong, Deyong Tong, Xiuna Shi, Sirong Wei, Yongguo Cai. lncRNA HIT000218960 enhances resistance to 5‑fluorouracil by promoting HMGA2 and activating the AKT/mTOR/P70S6K pathway in gastric cancer cells. Experimental and Therapeutic Medicine 2022; 24(2) doi: 10.3892/etm.2022.11454
|
| 25 |
Chong Kun Im, Hei-Cheul Jeung, Sun Young Rha, Nae Choon Yoo, Sung Hoon Noh, Jae Kyung Roh, Hyun Cheol Chung. A phase II study of paclitaxel combined with infusional 5-fluorouracil and low-dose leucovorin for advanced gastric cancer. Cancer Chemotherapy and Pharmacology 2007; 61(2): 315 doi: 10.1007/s00280-007-0508-6
|
| 26 |
Elisabete Fernandes, Dylan Ferreira, Andreia Peixoto, Rui Freitas, Marta Relvas-Santos, Carlos Palmeira, Gabriela Martins, Anabela Barros, Lúcio Lara Santos, Bruno Sarmento, José Alexandre Ferreira. Glycoengineered nanoparticles enhance the delivery of 5-fluoroucil and paclitaxel to gastric cancer cells of high metastatic potential. International Journal of Pharmaceutics 2019; 570: 118646 doi: 10.1016/j.ijpharm.2019.118646
|
| 27 |
Muhammad Abbas, Alessia Faggian, Dahiru Nasiru Sintali, Ghulam Jilany Khan, Shagufta Naeem, Meiqi Shi, Chen Dingding. Current and future biomarkers in gastric cancer. Biomedicine & Pharmacotherapy 2018; 103: 1688 doi: 10.1016/j.biopha.2018.04.178
|
| 28 |
|
| 29 |
Yutaka Yonemura, Yoshio Endo, Tohru Obata, Takuma Sasaki. Recent advances in the treatment of peritoneal dissemination of gastrointestinal cancers by nucleoside antimetabolites. Cancer Science 2007; 98(1): 11 doi: 10.1111/j.1349-7006.2006.00350.x
|
| 30 |
Hyun Jung Kim, Yea Bin Cho, Kyun Heo, Ji Woong Kim, Ha Gyeong Shin, Eun-bi Lee, Seong-Min Park, Jong Bae Park, Sukmook Lee. Targeting cell surface glucose-regulated protein 94 in gastric cancer with an anti-GRP94 human monoclonal antibody. BMB Reports 2024; 57(4): 188 doi: 10.5483/BMBRep.2023-0195
|
| 31 |
Pritam-Bhagwan Bhosale, Preethi Vetrivel, Sang-Eun Ha, Hun-Hwan Kim, Jeong-Doo Heo, Chung-Kil Won, Seong-Min Kim, Gon-Sup Kim. Iridin Induces G2/M Phase Cell Cycle Arrest and Extrinsic Apoptotic Cell Death through PI3K/AKT Signaling Pathway in AGS Gastric Cancer Cells. Molecules 2021; 26(9): 2802 doi: 10.3390/molecules26092802
|
| 32 |
Michael Gubanski, Anders Johnsson, Eva Fernebro, Lianna Kadar, Ingegerd Karlberg, Petra Flygare, Åke Berglund, Bengt Glimelius, Pehr A. Lind. Randomized phase II study of sequential docetaxel and irinotecan with 5-fluorouracil/folinic acid (leucovorin) in patients with advanced gastric cancer: the GATAC trial. Gastric Cancer 2010; 13(3): 155 doi: 10.1007/s10120-010-0553-4
|
| 33 |
Hyun-Kyung Jung, Kai Wang, Min Kyu Jung, In-San Kim, Byung-Heon Lee, Subhash Gautam. In Vivo Near-Infrared Fluorescence Imaging of Apoptosis Using Histone H1-Targeting Peptide Probe after Anti-Cancer Treatment with Cisplatin and Cetuximab for Early Decision on Tumor Response. PLoS ONE 2014; 9(6): e100341 doi: 10.1371/journal.pone.0100341
|
| 34 |
N.F. Aykan, E. Idelevich. The role of UFT in advanced gastric cancer. Annals of Oncology 2008; 19(6): 1045 doi: 10.1093/annonc/mdn024
|
| 35 |
Mohd Aman Mohd Ateeq, Mayur Aalhate, Srushti Mahajan, Ujala Gupta, Indrani Maji, Kedar Khaparkhuntikar, Anish Dhuri, Namitha Mohan C., Saurabh Srivastava, Pankaj Kumar Singh. Multifunctional Nanocomposites for Targeted Drug Delivery in Cancer Therapy. 2024; : 257 doi: 10.1016/B978-0-323-95303-0.00006-X
|
| 36 |
Atilla Celik, Aysun Simsek Celik, Ediz Altinli, Omer Beykal, Kasim Caglayan, Neset Koksal. Left gastric and right hepatic artery anomalies in a patient with gastric cancer: images for surgeons. The American Journal of Surgery 2011; 202(2): e13 doi: 10.1016/j.amjsurg.2010.04.028
|
| 37 |
Ponmathi Panneerpandian, Divya Bhaskar Rao, Kumaresan Ganesan. Calcium channel blockers lercanidipine and amlodipine inhibit YY1/ERK/TGF-β mediated transcription and sensitize the gastric cancer cells to doxorubicin. Toxicology in Vitro 2021; 74: 105152 doi: 10.1016/j.tiv.2021.105152
|
| 38 |
Stefan Peinert, Wilfried Grothe, Alexander Stein, Lutz P. Müller, Joern Ruessel, Wieland Voigt, Hans-Joachim Schmoll, Dirk Arnold. Safety and efficacy of weekly 5-fluorouracil/ folinic acid/oxaliplatin/irinotecan in the first-line treatment of gastrointestinal cancer. Therapeutic Advances in Medical Oncology 2010; 2(3): 161 doi: 10.1177/1758834010365061
|
| 39 |
Zhengyun Zou, Li Xie, Jia Wei, Lixia Yu, Xiaoping Qian, Junhao Chen, Tingting Wang, Baorui Liu. Synergistic anti-proliferative effects of gambogic acid with docetaxel in gastrointestinal cancer cell lines. BMC Complementary and Alternative Medicine 2012; 12(1) doi: 10.1186/1472-6882-12-58
|
| 40 |
Hun Hwan Kim, Sang Eun Ha, Min Yeong Park, Se Hyo Jeong, Pritam Bhagwan Bhosale, Abuyaseer Abusaliya, Chung Kil Won, Jeong Doo Heo, Meejung Ahn, Je Kyung Seong, Hyun Wook Kim, Gon Sup Kim. Identification of Kynurenic Acid-Induced Apoptotic Biomarkers in Gastric Cancer-Derived AGS Cells through Next-Generation Transcriptome Sequencing Analysis. Nutrients 2022; 15(1): 193 doi: 10.3390/nu15010193
|
| 41 |
A. Thelen, S. Jonas, C. Benckert, E. Lopez-Hänninen, U. Neumann, B. Rudolph, G. Schumacher, P. Neuhaus. Liver resection for metastatic gastric cancer. European Journal of Surgical Oncology (EJSO) 2008; 34(12): 1328 doi: 10.1016/j.ejso.2008.01.022
|
| 42 |
V Catalano, F Graziano, D Santini, S D'Emidio, A M Baldelli, D Rossi, B Vincenzi, P Giordani, P Alessandroni, E Testa, G Tonini, G Catalano. Second-line chemotherapy for patients with advanced gastric cancer: who may benefit?. British Journal of Cancer 2008; 99(9): 1402 doi: 10.1038/sj.bjc.6604732
|
| 43 |
Matthew Trendowski. Exploiting the cytoskeletal filaments of neoplastic cells to potentiate a novel therapeutic approach. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2014; 1846(2): 599 doi: 10.1016/j.bbcan.2014.09.007
|
| 44 |
Tianyu Cao, Yuanyuan Lu, Qi Wang, Hongqiang Qin, Hongwei Li, Hao Guo, Minghui Ge, Sarah E. Glass, Bhuminder Singh, Wenyao Zhang, Jiaqiang Dong, Feng Du, Airong Qian, Ye Tian, Xin Wang, Cunxi Li, Kaichun Wu, Daiming Fan, Yongzhan Nie, Robert J. Coffey, Xiaodi Zhao. A CGA/EGFR/GATA2 positive feedback circuit confers chemoresistance in gastric cancer. Journal of Clinical Investigation 2022; 132(6) doi: 10.1172/JCI154074
|
| 45 |
Isha Rani, Kim Vaiphei, Navneet Agnihotri. Supplementation of fish oil augments efficacy and attenuates toxicity of 5-fluorouracil in 1,2-dimethylhydrazine dihydrochloride/dextran sulfate sodium-induced colon carcinogenesis. Cancer Chemotherapy and Pharmacology 2014; 74(2): 309 doi: 10.1007/s00280-014-2497-6
|
| 46 |
Binghong Xiong, Li Ma, Wei Huang, Yong Cheng, Qikang Zhao, Jingshan Liu. WITHDRAWN: Clinical effectiveness of neoadjuvant chemotherapy in advanced gastric cancer: An updated meta-analysis of 12 randomized controlled trials. Surgical Oncology 2014; doi: 10.1016/j.suronc.2014.11.005
|
| 47 |
Wongwarut Boonyanugomol, Kamolchanok Rukseree, Pornpan Prapatpong, Onrapak Reamtong, Seung-Chul Baik, Myunghwan Jung, Min-Kyoung Shin, Hyung-Lyun Kang, Woo-Kon Lee. An In Vitro Anti-Cancer Activity of Ocimum tenuiflorum Essential Oil by Inducing Apoptosis in Human Gastric Cancer Cell Line. Medicina 2021; 57(8): 784 doi: 10.3390/medicina57080784
|
| 48 |
Roberto Persiani, Stefano Rausei, Carmelo Pozzo, Alberto Biondi, Carlo Barone, Ferdinando C. M. Cananzi, Giovanni Schinzari, Domenico D’Ugo. 7-Year Survival Results of Perioperative Chemotherapy with Epidoxorubicin, Etoposide, and Cisplatin (EEP) in Locally Advanced Resectable Gastric Cancer: Up-to-date Analysis of a Phase-II Study. Annals of Surgical Oncology 2008; 15(8): 2146 doi: 10.1245/s10434-008-9982-2
|
| 49 |
Koji Oba. Efficacy of adjuvant chemotherapy using tegafur-based regimen for curatively resected gastric cancer: update of a meta-analysis. International Journal of Clinical Oncology 2009; 14(2): 85 doi: 10.1007/s10147-009-0877-4
|
| 50 |
Mallika Tewari, Shipra Sahai, Raghvendra R. Mishra, Sunit K. Shukla, Hari S. Shukla. Dendritic cell therapy in advanced gastric cancer: A promising new hope?. Surgical Oncology 2012; 21(3): 164 doi: 10.1016/j.suronc.2012.03.003
|
| 51 |
FEI YUAN, HAILONG SHI, JUN JI, QU CAI, XUEHUA CHEN, YINGYAN YU, BINGYA LIU, ZHENGGANG ZHU, JUN ZHANG. Capecitabine metronomic chemotherapy inhibits the proliferation of gastric cancer cells through anti-angiogenesis. Oncology Reports 2015; 33(4): 1753 doi: 10.3892/or.2015.3765
|
| 52 |
JUN-SONG LIU, SHI-CAI HE, ZHENG-LIANG ZHANG, RUI CHEN, LIN FAN, GUANG-LIN QIU, SHUAI CHANG, LIANG LI, XIANG-MING CHE. Anticancer effects of β-elemene in gastric cancer cells and its potential underlying proteins: A proteomic study. Oncology Reports 2014; 32(6): 2635 doi: 10.3892/or.2014.3490
|
| 53 |
Bin Wu, Jin-Shui Zhu, Yi Zhang, Wei-Ming Shen, Qiang Zhang. Predictive value of MTT assay as an <italic>in vitro</italic> chemosensitivity testing for gastric cancer: One institution’s experience. World Journal of Gastroenterology 2008; 14(19): 3064-3068 doi: 10.3748/wjg.14.3064
|
| 54 |
Xuefei Zhao, Xia Xia, Xinyue Wang, Mingze Bai, Dongdong Zhan, Kunxian Shu. Deep Learning-Based Protein Features Predict Overall Survival and Chemotherapy Benefit in Gastric Cancer. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.847706
|
| 55 |
C. Gravalos, A. Jimeno. HER2 in gastric cancer: a new prognostic factor and a novel therapeutic target. Annals of Oncology 2008; 19(9): 1523 doi: 10.1093/annonc/mdn169
|
| 56 |
Kun Gao, Qi Liang, Zhi-Hao Zhao, You-Fen Li, Shu-Feng Wang. Synergistic anticancer properties of docosahexaenoic acid and 5-fluorouracil through interference with energy metabolism and cell cycle arrest in human gastric cancer cell line AGS cells. World Journal of Gastroenterology 2016; 22(10): 2971-2980 doi: 10.3748/wjg.v22.i10.2971
|
| 57 |
Dhananjay Shukla, Saurabh Saxena, Pranav Kumar Prabhakar. Novel therapeutic approaches for gastrointestinal malignancies. Diagnostics and Therapeutic Advances in GI Malignancies 2020; : 115 doi: 10.1007/978-981-15-5471-1_8
|
| 58 |
Ekaterina Proskuriakova, Vaisny Balamurali, Anuradha Hooda, Paramjeet Khosla. Metastatic gastric adenocarcinoma discovered in the bone marrow. BMJ Case Reports 2024; 17(9): e260217 doi: 10.1136/bcr-2024-260217
|
| 59 |
Yasuhide Yamada, Tokuzo Arao, Takuji Gotoda, Hirokazu Taniguchi, Ichiro Oda, Kuniaki Shirao, Yasuhiro Shimada, Tetsuya Hamaguchi, Ken Kato, Tetsutaro Hamano, Fumiaki Koizumi, Tomohide Tamura, Daizo Saito, Tadakazu Shimoda, Makoto Saka, Takeo Fukagawa, Hitoshi Katai, Takeshi Sano, Mitsuru Sasako, Kazuto Nishio. Identification of prognostic biomarkers in gastric cancer using endoscopic biopsy samples. Cancer Science 2008; 99(11): 2193 doi: 10.1111/j.1349-7006.2008.00935.x
|
| 60 |
Guoming Hu, Kefang Zhong, Songxiang Wang, Shimin Wang, Qiannan Ding, Feng Xu, Wei Chen, Pu Cheng, Liming Huang. Cellular immunotherapy plus chemotherapy ameliorates survival in gastric cancer patients: a meta-analysis. International Journal of Clinical Oncology 2020; 25(10): 1747 doi: 10.1007/s10147-020-01750-6
|
| 61 |
Haidong Cheng, Gaowa Sharen, Zhaoyang Wang, Jing Zhou. LncRNA UCA1 Enhances Cisplatin Resistance by Regulating CYP1B1-mediated Apoptosis via miR-513a-3p in Human Gastric Cancer. Cancer Management and Research 2021; : 367 doi: 10.2147/CMAR.S277399
|
| 62 |
Hsiu-Tzu Wang, Su-Peng Yeh. Successful treatment with continuous high-dose 5-fluorouracil infusion, followed by oral capecitabine in a patient with advanced gastric cancer with bone marrow metastasis and microangiopathic hemolytic anemia. Journal of Cancer Research and Practice 2020; 7(4): 167 doi: 10.4103/JCRP.JCRP_20_20
|
| 63 |
A. M. Mongan, R. Kalachand, S. King, N. J. O’Farrell, D. Power, N. Ravi, C. Muldoon, K. O’Byrne, J. V. Reynolds. Outcomes in gastric and junctional cancer using neoadjuvant and adjuvant chemotherapy (epirubicin, oxaliplatin, and capecitabine) and radical surgery. Irish Journal of Medical Science (1971 -) 2015; 184(2): 417 doi: 10.1007/s11845-014-1135-y
|
| 64 |
Masanori Tokunaga, Shigekazu Ohyama, Souya Nunobe, Naoki Hiki, Tetsu Fukunaga, Yasuyuki Seto, Toshiharu Yamaguchi. Advanced gastric cancer with a duplicated hepatic artery: preoperative diagnostic value of multidetector-row computed tomography for surgical resection. Gastric Cancer 2007; 10(3): 191 doi: 10.1007/s10120-007-0430-y
|
| 65 |
Melissa J. LaBonte, Dongyun Yang, Wu Zhang, Peter M. Wilson, Yasir M. Nagarwala, Kevin M. Koch, Colleen Briner, Tomomi Kaneko, Sun-Young Rha, Oleg Gladkov, Susan G. Urba, Dina Sakaeva, Michael J. Pishvaian, Ruey-Kuen Hsieh, Wei-Ping Lee, Heinz-Josef Lenz. A Phase II Biomarker-Embedded Study of Lapatinib plus Capecitabine as First-line Therapy in Patients with Advanced or Metastatic Gastric Cancer. Molecular Cancer Therapeutics 2016; 15(9): 2251 doi: 10.1158/1535-7163.MCT-15-0908
|
| 66 |
Aristotelis Bamias, M. Karina, P. Papakostas, I. Kostopoulos, M. Bobos, G. Vourli, E. Samantas, Ch. Christodoulou, G. Pentheroudakis, D. Pectasides, M. A. Dimopoulos, G. Fountzilas. A randomized phase III study of adjuvant platinum/docetaxel chemotherapy with or without radiation therapy in patients with gastric cancer. Cancer Chemotherapy and Pharmacology 2010; 65(6): 1009 doi: 10.1007/s00280-010-1256-6
|
| 67 |
Phu Tran, Cham Nguyen, Samuel J. Klempner. Targeting the Phosphatidylinositol-3-kinase Pathway in Gastric Cancer: Can Omics Improve Outcomes?. International Neurourology Journal 2016; 20(Suppl 2): S131 doi: 10.5213/inj.1632740.370
|
| 68 |
Mariana R. DeFreitas, Amadu Toronka, Marybeth A. Nedrud, Sarah Cubberley, Islam H. Zaki, Brandon Konkel, Hope E. Uronis, Manisha Palta, Dan G. Blazer, Kyle J. Lafata, Mustafa R. Bashir. CT-derived body composition measurements as predictors for neoadjuvant treatment tolerance and survival in gastroesophageal adenocarcinoma. Abdominal Radiology 2022; 48(1): 211 doi: 10.1007/s00261-022-03695-y
|
| 69 |
Fernando Rivera, Cristina Grávalos, Rocío García-Carbonero. SEOM clinical guidelines for the diagnosis and treatment of gastric adenocarcinoma. Clinical and Translational Oncology 2012; 14(7): 528 doi: 10.1007/s12094-012-0836-9
|
| 70 |
M. Janusz Mezynski, Angela M. Farrelly, Mattia Cremona, Aoife Carr, Clare Morgan, Julie Workman, Paul Armstrong, Jennifer McAuley, Stephen Madden, Joanna Fay, Katherine M. Sheehan, Elaine W. Kay, Ciara Holohan, Yasir Elamin, Shereen Rafee, Patrick G. Morris, Oscar Breathnach, Liam Grogan, Bryan T. Hennessy, Sinead Toomey. Targeting the PI3K and MAPK pathways to improve response to HER2-targeted therapies in HER2-positive gastric cancer. Journal of Translational Medicine 2021; 19(1) doi: 10.1186/s12967-021-02842-1
|
| 71 |
Deirdre P Cronin-Fenton, Margaret M Mooney, Limin X Clegg, Linda C Harlan. Treatment and survival in a population-based sample of patients diagnosed with gastroesophageal adenocarcinoma. World Journal of Gastroenterology 2008; 14(20): 3165-3173 doi: 10.3748/wjg.14.3165
|